Literature DB >> 19126397

MicroRNA-dependent regulation of cKit in cutaneous melanoma.

O Igoucheva1, V Alexeev.   

Abstract

Loss of cKit receptor in cutaneous melanomas was attributed to the down-regulation of AP2 transcription factor. Our analysis of 27 melanoma cell lines showed no correlation between AP2 and c-kit expression. Suggesting a post-transcriptional mechanism of cKit down-modulation, we performed genome-wide microRNA (miRNA) expression profiling and found that several miRNA species are commonly up-regulated in melanomas. Among them was mir-221, which can directly interact with c-kit 3'UTR and inhibit cKit protein translation. Observed inverse correlation of the c-kit and mir-221 expression in various melanocytic cells pointed to its involvement in regulation of cKit in melanoma. Moreover, a series of functional assays demonstrated that mir-221 could directly inhibit cKit, p27(Kip1) and, possibly, other pivotal proteins in melanoma. Collectively, the studies presented here indicate that mir-221 could be a novel therapeutic target for the treatment of cutaneous melanoma. They also suggest that regulation of expression and functional activity of identified up-regulated miRNAs should be further studied in the context of malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19126397     DOI: 10.1016/j.bbrc.2008.12.152

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  39 in total

Review 1.  The role of microRNAs in skin fibrosis.

Authors:  Olubukola Babalola; Andrew Mamalis; Hadar Lev-Tov; Jared Jagdeo
Journal:  Arch Dermatol Res       Date:  2013-11       Impact factor: 3.017

2.  Melanoma MicroRNA signature predicts post-recurrence survival.

Authors:  Miguel F Segura; Ilana Belitskaya-Lévy; Amy E Rose; Jan Zakrzewski; Avital Gaziel; Douglas Hanniford; Farbod Darvishian; Russell S Berman; Richard L Shapiro; Anna C Pavlick; Iman Osman; Eva Hernando
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

Review 3.  Pivotal MicroRNAs in Melanoma: A Mini-Review.

Authors:  Zhenjun Deng; Jingang Hao; Dongyun Lei; Yongjing He; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

Review 4.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

Authors:  Muhammad Nauman Aftab; Marcel E Dinger; Ranjan J Perera
Journal:  Arch Biochem Biophys       Date:  2014-07-24       Impact factor: 4.013

Review 5.  miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.

Authors:  Paige E Bennett; Lynne Bemis; David A Norris; Yiqun G Shellman
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

6.  MicroRNAs 221 and 222 regulate the undifferentiated state in mammalian male germ cells.

Authors:  Qi-En Yang; Karen E Racicot; Amy V Kaucher; Melissa J Oatley; Jon M Oatley
Journal:  Development       Date:  2012-12-05       Impact factor: 6.868

Review 7.  Role of miRNAs in the progression of malignant melanoma.

Authors:  D W Mueller; A K Bosserhoff
Journal:  Br J Cancer       Date:  2009-07-28       Impact factor: 7.640

8.  Microrna profiling analysis of differences between the melanoma of young adults and older adults.

Authors:  Drazen M Jukic; Uma N M Rao; Lori Kelly; Jihad S Skaf; Laura M Drogowski; John M Kirkwood; Monica C Panelli
Journal:  J Transl Med       Date:  2010-03-19       Impact factor: 5.531

9.  The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.

Authors:  Joseph Mazar; Katherine DeYoung; Divya Khaitan; Edward Meister; Alvin Almodovar; James Goydos; Animesh Ray; Ranjan J Perera
Journal:  PLoS One       Date:  2010-11-01       Impact factor: 3.240

10.  Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.

Authors:  Yuanyuan Li; David M Umbach; Leping Li
Journal:  Melanoma Res       Date:  2017-12       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.